December 7, 2022 — Ultromics has announced that its EchoGo Heart Failure, an artificial intelligence (AI) platform for echocardiography, with the potential to revolutionize the diagnosis of heart failure with preserved ejection fraction (HFpEF), has received US Food and Drug Administration (FDA) clearance.

ACC Cardiovascular Summit 2023

ICE2023 Imaging Conference and Expo

December 5, 2022 —  The U.S. Food and Drug Administration (FDA) is alerting health care facilities and providers of a shortage of Getinge Maquet/Datascope Intra-Aortic Balloon Pump (IABP) devices, including limited supplies of IAB catheters, new Cardiosave IABPs, and Cardiosave IABP parts. 

Recommendations 

The FDA recommends that health care facilities and providers who use Getinge Maquet/Datascope IAB catheters or IABP devices: 

Nuclear Cardiology Today


Here is a recap of what DAIC viewers found most interesting during the month of November:

1. Study Finds That Risk of Myocarditis After SARS-CoV-2 Vaccination is Increased But Very Low

2. Johnson & Johnson to Acquire Abiomed

December 2, 2022 —  Westchester resident, 62-year-old Miriam Nieves, is especially grateful this Thanksgiving season.

December 2, 2022 —  Boston Scientific Corporation has announced the first results from the ACURATE neo2 Post Market Clinical Follow-up (PMCF) study evaluating the performance of the ACURATE neo2TM Aortic Valve System.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now